Info@ThinkPinkRocks.com

Posts Tagged drug-discovery

Taking Clues from Nature for the Development of New Drugs

Add a Comment By Julie Grisham, MS, Science Writer/Editor   |  Monday, September 16, 2013 In this Q&A, Memorial Sloan-Kettering chemist Derek Tan discusses why natural products offer inspiration for the development of new drugs. read more

For More........

Making Clinical Trials More Efficient, Informative, and Effective

Add a Comment By Paul Sabbatini  |  Friday, July 26, 2013 The clinical trial remains our best tool to identify new therapies, but as with all tools, innovation is required if trials are to remain relevant.

For More........

Comparison of Drugs for Advanced Kidney Cancer Suggests Side Effects Are More Manageable with Newer Option

Add a Comment By Maureen Salamon, BA  |  Thursday, August 22, 2013 An international study led by Memorial Sloan-Kettering found that pazopanib (Votrient ® ) controls cancer as effectively as sunitinib (Sutent ® ) while improving patients’ quality of life. read more

For More........

A Recently Revealed Protein Structure Creates New Opportunities for Cancer Research and Drug Design

Add a Comment By Eva Kiesler, PhD, Science Writer/Editor   |  Thursday, May 30, 2013 In an eagerly awaited study, Memorial Sloan-Kettering researchers report on the molecular structure of mTOR, a protein commonly mutated in cancer. read more

For More........

Research Suggests a New Approach for Overcoming Resistance to a Targeted Therapy for Prostate Cancer

Add a Comment By Julie Grisham, MS, Science Writer/Editor   |  Tuesday, April 30, 2013 Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide.

For More........

Calibr, JDRF partner to research on promising type 1 diabetes therapeutic targets

The California Institute for Biomedical Research and JDRF announced a partnership today to apply Calibr’s drug discovery expertise to type 1 diabetes research projects in collaboration with academic investigators from JDRF’s network.

For More........

Developmental Biologist Lorenz Studer Comments on the 2012 Nobel Prize in Physiology or Medicine

Add a Comment By Eva Kiesler, PhD, Science Writer/Editor   |  Tuesday, December 11, 2012 Methods to generate stem cells have given scientists new ways to study some diseases and identify potential drugs, and could one day be used to rebuild diseased or damaged tissues in patients.

For More........
Page 2 of 212